Regulations for the Patent Linkage of Drugs Article 11

The generic drug permit license applicant shall, in accordance with Paragraph 1 of Article 48-12 in the Act, present a written notification, in which explains why the patent shall be revoked, or the patent is not infringed upon shall be specifically stated, accompanied by relevant documents and information.The written notification stated in the preceding Paragraph shall be using double-signed mail with a return receipt via the post office. The applicant shall also send return receipt copies and other documents which are sufficient to prove the service to the Central Competent Health Authority within 20 days after the next day to the service of the notification.